[ Price : $8.95]
FDA posts a final guidance entitled Promotional Labeling and Advertising Considerations for Prescription Biological Reference Prod...[ Price : $8.95]
FDA advises the companies manufacturing RSV therapies for infants that the agency is taking a new look at the therapies safety.[ Price : $8.95]
FDA warns Saint Paul, MN-based Envoy Medical about Quality System violations in its manufacturing of the Esteem II implantable hea...[ Price : $8.95]
FDA opens a broad investigation into reports of deaths in adults that may be linked to Covid-19 vaccines after probing pediatric d...[ Price : $8.95]
Two pharmacist-attorneys (BakerHostetler) urge Congress to strengthen federal restrictions on how senior FDA officials move into p...[ Price : $8.95]
CDER issues a Manual of Policies and Procedures for when a reference-listed drug switches from prescription to nonprescription mar...[ Price : $8.95]
CBER officials pen a new JAMA article signaling a major policy shift for cancer CAR T-cell therapies, moving away from reliance on...[ Price : $8.95]
Four Hogan Lovells attorneys describe a potential significant shift in Justice Department enforcement boundaries, especially invol...